Paclitaxel enhances therapeutic efficacy of the F8-IL2 immunocytokine to EDA-fibronectin–positive metastatic human melanoma xenografts

M Moschetta, F Pretto, A Berndt, K Galler, P Richter… - Cancer research, 2012 - AACR
The selective delivery of bioactive agents to tumors reduces toxicity and enhances the
efficacy of anticancer therapies. In this study, we show that the antibody F8, which …
被引用次数：112 相关文章
[PDF] academia.edu

[PDF][PDF] Paclitaxel Enhances Therapeutic Efficacy of the F8-IL2 Immunocytokine to EDA-Fibronectin–Positive Metastatic Human Melanoma Xenografts

M Moschetta, F Pretto, A Berndt, K Galler, P Richter… - Cancer Res, 2012 - academia.edu
The selective delivery of bioactive agents to tumors reduces toxicity and enhances the
efficacy of anticancer therapies. In this study, we show that the antibody F8, which …

Paclitaxel enhances therapeutic efficacy of the F8-IL2 immunocytokine to EDA-fibronectin-positive metastatic human melanoma xenografts

M Moschetta, F Pretto, A Berndt, K Galler… - Cancer …, 2012 - pubmed.ncbi.nlm.nih.gov
The selective delivery of bioactive agents to tumors reduces toxicity and enhances the
efficacy of anticancer therapies. In this study, we show that the antibody F8, which …

Paclitaxel enhances therapeutic efficacy of the F8-IL2 immunocytokine to EDA-fibronectin-positive metastatic human melanoma xenografts.

M Moschetta, F Pretto, A Berndt, K Galler… - Cancer …, 2012 - europepmc.org
The selective delivery of bioactive agents to tumors reduces toxicity and enhances the
efficacy of anticancer therapies. In this study, we show that the antibody F8, which …

Paclitaxel Enhances Therapeutic Efficacy of the F8-IL2 Immunocytokine to EDA-Fibronectin–Positive Metastatic Human Melanoma Xenografts

M Moschetta, F Pretto, A Berndt, K Galler, P Richter… - Cancer …, 2012 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The selective delivery of bioactive agents to
tumors reduces toxicity and enhances the efficacy of anticancer therapies. In this study, we …

Paclitaxel enhances therapeutic efficacy of the F8-IL2 immunocytokine to EDA-fibronectin-positive metastatic human melanoma xenografts

M Moschetta, F Pretto, A Berndt, K Galler… - CANCER …, 2012 - re.public.polimi.it
The selective delivery of bioactive agents to tumors reduces toxicity and enhances the
efficacy of anticancer therapies. In this study, we show that the antibody F8, which …

[引用][C] Paclitaxel Enhances Therapeutic Efficacy of the F8-IL2 Immunocytokine to EDA Fibronectin Positive Metastatic Human Melanoma Xenografts

M Moschetta, F Pretto, A Berndt, K Galler… - Cancer …, 2012 - research-collection.ethz.ch
Paclitaxel Enhances Therapeutic Efficacy of the F8-IL2 Immunocytokine to EDA Fibronectin
Positive Metastatic Human Melanoma Xenografts - Research Collection Header Upper Right …

[引用][C] Paclitaxel Enhances Therapeutic Efficacy of the F8-IL2 Immunocytokine to EDA-Fibronectin―Positive Metastatic Human Melanoma Xenografts

M MOSCHETTA, F PRETTO… - Cancer research …, 2012 - pascal-francis.inist.fr
Paclitaxel Enhances Therapeutic Efficacy of the F8-IL2 Immunocytokine to EDA-Fibronectin―Positive
Metastatic Human Melanoma Xenografts CNRS Inist Pascal-Francis CNRS Pascal and …